Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.

<h4>Background</h4> <p>Antimalarial drugs affect the central nervous system, but it is difficult to differentiate the effect of these drugs from that of the malaria illness. We conducted a systematic review to determine the association between anti-malarial drugs and mental and ne...

Bibliografski detalji
Glavni autori:	Bitta, M, Kariuki, S, Mwita, C, Gwer, S, Mwai, L, Newton, C
Format:	Journal article
Jezik:	English
Izdano:	Wellcome et al 2017

Slični predmeti

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis [version 2; referees: 2 approved]
od: Mary A. Bitta, i dr.
Izdano: (2017-06-01)

Diagnostic accuracy of clinical stroke scores for distinguishing stroke subtypes: A systematic review
od: Mwita, C, i dr.
Izdano: (2012)

Antiepileptic properties of quinine: A systematic review
od: Mwita, C, i dr.
Izdano: (2012)

Priority mental, neurological and substance use disorders in rural Kenya: Traditional health practitioners’ and primary health care workers’ perspectives
od: Bitta, M, i dr.
Izdano: (2019)

Burden of neurodevelopmental disorders in low and middle-income countries: A systematic review and meta-analysis
od: Bitta, M, i dr.
Izdano: (2017)

Effectiveness of participatory video in lowering stigma against people with mental, neurological and substance use disorders in Kenya
od: Bitta, MA, i dr.
Izdano: (2023)

The role for osmotic agents in children with acute encephalopathies: a systematic review
od: Gwer, S, i dr.
Izdano: (2010)

Risk of suicidality in mental and neurological disorders in low and middle-income countries: A systematic review and meta-analysis
od: Ongeri, L, i dr.
Izdano: (2023)

Accuracy of clinical stroke scores for distinguishing stroke subtypes in resource poor settings: A systematic review of diagnostic test accuracy.
od: Mwita, C, i dr.
Izdano: (2014)

An overview of mental health care system in Kilifi, Kenya: results from an initial assessment using the World Health Organization's Assessment Instrument for Mental Health Systems.
od: Bitta, M, i dr.
Izdano: (2017)

Priority mental, neurological and substance use disorders in rural Kenya: Traditional health practitioners' and primary health care workers' perspectives.
od: Mary A Bitta, i dr.
Izdano: (2019-01-01)

The activities of various antimalarial drugs on Plasmodium falciparum isolates in Kilifi Kenya and studies on mechanisms of resistance
od: Mwai, L
Izdano: (2011)

Neurological manifestations of falciparum malaria.
od: Newton, C, i dr.
Izdano: (1998)

Risk of suicidality in mental and neurological disorders in low and middle-income countries: A systematic review and meta-analysis
od: Linnet Ongeri, i dr.
Izdano: (2023-05-01)

The role for osmotic agents in children with acute encephalopathies: a systematic review
od: Mwai Leah, i dr.
Izdano: (2010-04-01)

Public Awareness and Identification of Counterfeit Drugs in Tanzania: A View on Antimalarial Drugs
od: Linus Mhando, i dr.
Izdano: (2016-01-01)

The effectiveness of a multipronged approach to tackle stigma against people with mental, neurological and substance use disorders in Kilifi, Kenya
od: Bitta, MA
Izdano: (2022)

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
od: Earnest Oghenesuvwe Erhirhie, i dr.
Izdano: (2021-01-01)

Antimalarial drug quality: Methods to detect suspect drugs
od: Kaur, H, i dr.
Izdano: (2010)

Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
od: Tâmara Natasha Gonzaga de Andrade Santos, i dr.
Izdano: (2020-01-01)

An overview of mental health care system in Kilifi, Kenya: results from an initial assessment using the World Health Organization’s Assessment Instrument for Mental Health Systems
od: Mary A. Bitta, i dr.
Izdano: (2017-04-01)

Monitoring antimalarial drug efficacy - Reply
od: Mayxay, M, i dr.
Izdano: (2004)

A link between poor quality antimalarials and malaria drug resistance?
od: Newton, P, i dr.
Izdano: (2016)

A link between poor quality antimalarials and malaria drug resistance?
od: Newton, P, i dr.
Izdano: (2016)

Prevalence of neurological manifestations in COVID-19 and their association with mortality
od: C.R. Carlos, i dr.
Izdano: (2021-01-01)

Prevalence of malaria and predisposing factors to antimalarial drug resistance in Ota
od: G.I. Olasehinde
Izdano: (2014-04-01)

Quality of Antimalarial Drugs in East Africa: A Systematic Review
od: Girma M, i dr.
Izdano: (2022-10-01)

Neurological manifestations of malaria
od: Gustavo C. Román, i dr.
Izdano: (1992-03-01)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
od: Shibeshi MA, i dr.
Izdano: (2020-11-01)

Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis
od: Rizaldy Taslim Pinzon, i dr.
Izdano: (2022-08-01)

A systematic overview of published antimalarial drug trials.
od: Myint, H, i dr.
Izdano: (2004)

Antimalarial drugs in pregnancy: a review.
od: Nosten, F, i dr.
Izdano: (2006)

Neurological manifestations of coronavirus infections – a systematic review
od: Jesper Almqvist, i dr.
Izdano: (2020-10-01)

Neurological manifestations of COVID-19: a systematic review
od: Gaurav Nepal, i dr.
Izdano: (2020-07-01)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
od: Price, R, i dr.
Izdano: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
od: Price, R, i dr.
Izdano: (2007)

Antimalarial drug resistance
od: White, N
Izdano: (2004)

Cardiotoxicity of antimalarial drugs.
od: White, N
Izdano: (2007)

Antimalarial drug resistance.
od: White, N
Izdano: (2004)

Effectiveness of antimalarial drugs.
od: Baird, J
Izdano: (2005)